These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35710733)

  • 21. TMTV-Net: fully automated total metabolic tumor volume segmentation in lymphoma PET/CT images - a multi-center generalizability analysis.
    Yousefirizi F; Klyuzhin IS; O JH; Harsini S; Tie X; Shiri I; Shin M; Lee C; Cho SY; Bradshaw TJ; Zaidi H; Bénard F; Sehn LH; Savage KJ; Steidl C; Uribe CF; Rahmim A
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1937-1954. PubMed ID: 38326655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A different perspective on PET/CT before treatment in patients with Hodgkin lymphoma: importance of volumetric and dissemination parameters.
    Aksu A; Küçüker KA; Solmaz Ş; Turgut B
    Ann Hematol; 2024 Mar; 103(3):813-822. PubMed ID: 37964021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Artificial Intelligence in PET/CT Imaging for Management of Lymphoma.
    Veziroglu EM; Farhadi F; Hasani N; Nikpanah M; Roschewski M; Summers RM; Saboury B
    Semin Nucl Med; 2023 May; 53(3):426-448. PubMed ID: 36870800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of baseline FDG PET/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma.
    Toledano MN; Desbordes P; Banjar A; Gardin I; Vera P; Ruminy P; Jardin F; Tilly H; Becker S
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):680-688. PubMed ID: 29344718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic tumour volume in Hodgkin lymphoma-A comparison between manual and AI-based analysis.
    Sadik M; Barrington SF; Trägårdh E; Saboury B; Nielsen AL; Jakobsen AL; Gongora JLL; Urdaneta JL; Kumar R; Edenbrandt L
    Clin Physiol Funct Imaging; 2024 May; 44(3):220-227. PubMed ID: 38011940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The added prognostic values of baseline PET dissemination parameter in patients with angioimmunoblastic T-cell lymphoma.
    Gong H; Tang B; Li T; Li J; Tang L; Ding C
    EJHaem; 2023 Feb; 4(1):67-77. PubMed ID: 36819177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma.
    Cottereau AS; Lanic H; Mareschal S; Meignan M; Vera P; Tilly H; Jardin F; Becker S
    Clin Cancer Res; 2016 Aug; 22(15):3801-9. PubMed ID: 26936916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [
    Zhang X; Chen L; Jiang H; He X; Feng L; Ni M; Ma M; Wang J; Zhang T; Wu S; Zhou R; Jin C; Zhang K; Qian W; Chen Z; Zhuo C; Zhang H; Tian M
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1298-1310. PubMed ID: 34651227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the prognostic value of different methods of calculating the tumour metabolic volume with
    Guzmán Ortiz S; Mucientes Rasilla J; Vargas Núñez JA; Royuela A; Navarro Matilla B; Mitjavila Casanovas M
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(6):340-346. PubMed ID: 32646783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Importance of Bone Marrow Uptake on Baseline
    Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
    Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of baseline metabolic tumor volume and total lesion glycolysis in patients with lymphoma: A meta-analysis.
    Guo B; Tan X; Ke Q; Cen H
    PLoS One; 2019; 14(1):e0210224. PubMed ID: 30625203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of the metabolic bulk volume in patients with diffuse large B-cell lymphoma on baseline
    Delaby G; Hubaut MA; Morschhauser F; Besson A; Huglo D; Herbaux C; Baillet C
    Leuk Lymphoma; 2020 Jul; 61(7):1584-1591. PubMed ID: 32100597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of the methodological aspects of the dichotomization of total metabolic tumor volume measured through baseline fluorine-18 fluorodeoxyglucose PET on survival prediction in lymphoma.
    Lue KH; Chen YH; Wu YF; Liu SH
    Nucl Med Commun; 2023 Jan; 44(1):74-80. PubMed ID: 36514929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Full automation of total metabolic tumor volume from FDG-PET/CT in DLBCL for baseline risk assessments.
    Jemaa S; Paulson JN; Hutchings M; Kostakoglu L; Trotman J; Tracy S; de Crespigny A; Carano RAD; El-Galaly TC; Nielsen TG; Bengtsson T
    Cancer Imaging; 2022 Aug; 22(1):39. PubMed ID: 35962459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total tumor burden in lymphoma - an evolving strong prognostic parameter.
    Meignan M; Cottereau AS; Specht L; Mikhaeel NG
    Br J Radiol; 2021 Nov; 94(1127):20210448. PubMed ID: 34379496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2-[
    Albano D; Calabrò A; Talin A; Dondi F; Pagani C; Tucci A; Treglia G; Bertagna F
    Ann Hematol; 2024 Jul; 103(7):2419-2427. PubMed ID: 38374254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic tumor burden on baseline
    Chen S; He K; Feng F; Wang S; Yin Y; Fu H; Wang H
    Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1830-1839. PubMed ID: 31187163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell Lymphoma.
    Cottereau AS; Hapdey S; Chartier L; Modzelewski R; Casasnovas O; Itti E; Tilly H; Vera P; Meignan MA; Becker S
    J Nucl Med; 2017 Feb; 58(2):276-281. PubMed ID: 27754905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline
    Aide N; Fruchart C; Nganoa C; Gac AC; Lasnon C
    Eur Radiol; 2020 Aug; 30(8):4623-4632. PubMed ID: 32248365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline
    Boellaard R; Buvat I; Nioche C; Ceriani L; Cottereau AS; Guerra L; Hicks RJ; Kanoun S; Kobe C; Loft A; Schöder H; Versari A; Voltin CA; Zwezerijnen GJC; Zijlstra JM; Mikhaeel NG; Gallamini A; El-Galaly TC; Hanoun C; Chauvie S; Ricci R; Zucca E; Meignan M; Barrington SF
    J Nucl Med; 2024 Sep; 65(9):1343-1348. PubMed ID: 39089812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.